About This Blog
In this blog, Robert Gadimian covers biotech stocks that are hot for the moment. The analysis will be based on technical analysis of stock’s chart, company’s portfolio, upcoming catalyst(s). A top-line overview of the company, its products, clinical studies and catalysts, an entry and exit point will be provided. I will set stop losses (meaning when to sell if the stock goes down) and will honor them so the trades could be very fast if the stock is not behaving as expected.
The opinions are mine and are not intended to be used as a personalized investment recommendation. Please note I am NOT a certified financial adviser.”
Leave us a message
Please don’t hesitate to contact us for more information. You can also send your messages to email address below: